TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director November 19, 1999
TCL Archive Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure? September 2, 1977